Hence, our study confirms the role of AQP-4 as a key component of the glymphatic system and its potential role as a marker of glymphatic impairment, also in the context of psychiatric disorders [62, 63, 70, 71, 74, 86, 87]. This evidence concerns the gene AQP4 and psychiatric disorder.